Media Advisory: Theratechnologies to Present at RBC Capital Markets Conference
(firmenpresse) - MONTREAL, CANADA -- (Marketwire) -- 02/23/12 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH)(NASDAQ: THER) today announced that John-Michel T. Huss, President and Chief Executive Officer of Theratechnologies, is scheduled to present at the 2012 RBC Capital Markets Global Healthcare Conference in New York City, on February 29, 2012 at 2:30 p.m. ET. Financial analysts, media and other interested individuals are invited to listen to the live webcast on Theratechnologies' corporate website at .
About Theratechnologies
Theratechnologies (TSX: TH)(NASDAQ: THER) is a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor (GRF) peptides. Further information about Theratechnologies is available on the Company's website at , on SEDAR at and on the Securities and Exchange Commission's website at .
Contacts:
Roch Landriault
NATIONAL Public Relations
514 843-2345
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 23.02.2012 - 09:00 Uhr
Sprache: Deutsch
News-ID 1086155
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
MONTREAL, CANADA
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 105 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Media Advisory: Theratechnologies to Present at RBC Capital Markets Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
Theratechnologies Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
